Avita Medical, Inc. Common Stock
$10.45
$0.24 (+2.35%)
$10.09Day Range$10.67
Key Statistics
Market Cap
$323.19M
Shares Outstanding
30.9M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Mar 8, 2012
Round Lot
100
Locale
US
Trading Data
Day Open
$10.15
Day High
$10.67
Day Low
$10.09
Volume
311.3K
VWAP
$10.43
Prev Close
$10.21
Transactions
--
Acc. Volume
--
About Avita Medical, Inc. Common Stock
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841226 employees28159 AVENUE STANFORD, VALENCIA, CA, 91355661-568-1317IPO Mar 8, 2012US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001762303
- Composite FIGI
- BBG00TD18T43
- Share Class FIGI
- BBG00TD18TF1
- Ticker Root
- RCEL
- SIC Code
- 3841
About Avita Medical, Inc. Common Stock (RCEL) Stock
Avita Medical, Inc. Common Stock (RCEL) closed the 2026-09-16 session at $10.45, up 2.35% versus the previous close (+0.24). The stock opened at $10.15 and traded between $10.09 and $10.67 during that session. Session trading volume was 311K shares. The volume-weighted average price (VWAP) is $10.43.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Avita Medical, Inc. Common Stock has a market capitalization of $323.2 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. RCEL is listed on the XNAS exchange. The company employs approximately 226 people. Avita Medical, Inc. Common Stock is headquartered in VALENCIA, CA. The recorded listing date is 2012-03-08.
On this page you can find market RCEL stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.